| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |